Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 63629-1564

2 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 63629-1564). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)
Chemical structure of Orphenadrine Citrate, showing the molecular arrangement of the active ingredient in the extended-release tablet form by Bryant Ranch Prepack.*
FDA Label Image

Label Image (Lbl636291564)

Label Image (Lbl636291564)
Label for Orphenadrine Citrate 100 mg extended-release tablet by Bryant Ranch Prepack. The label includes storage instructions to keep the product at room temperature (20-25°C/68-77°F) and a caution to keep all drugs out of reach of children. The label indicates a package of 20 tablets and references comparison to Norflex 100 mg ER Tablet by Novel Laboratories Inc. The product NDC is 63629-1564.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.